FIELD: medicine.
SUBSTANCE: invention relates to medicine. Method for diagnosing disorders of nucleic acid (NA) metabolism in critical patients is proposed. Concentration of oligonucleotides DNA and uric acid (UA) in blood serum (BS) is determined. Intensity index of the exchange of NA (AI NAM) is calculated. Index values of less than 30 % in critical patients indicate that NA breakdown prevails over de novo synthesis. Index values of higher than 30 % indicate a predominance of synthesis over the decomposition of the NA.
EFFECT: invention provides an effective diagnosis of metabolic disorders of NA in critical patients.
1 cl, 3 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BIOLOGICALLY ACTIVE FOOD ADDITIVE | 2014 |
|
RU2559066C1 |
| COMPOSITION FOR VEGETABLE COMPONENTS, WHICH HAS THE ABILITY TO REDUCE THE LEVEL OF URIC ACID IN BLOOD SERUM | 2018 |
|
RU2683570C1 |
| METHOD OF PREDICTION OF ISCHEMIC STROKE COURSE | 2007 |
|
RU2324941C1 |
| METHOD OF ASSESSING THE LEVEL OF OXIDATIVE STRESS IN PATIENTS WITH BURNS | 2022 |
|
RU2798309C1 |
| BIOLOGICALLY ACTIVE FOOD ADDITIVE WITH ANTIPARASITAL ACTIVITY | 2016 |
|
RU2621256C1 |
| EXPRESS DIAGNOSIS METHOD FOR DIAGNOSING ENDOGENOUS INTOXICATION CASES | 2004 |
|
RU2280865C1 |
| METHOD FOR ASSESSMENT OF CATTLE RESISTANCE TO TUBERCULOSIS | 2011 |
|
RU2452953C1 |
| METHOD FOR PREDICTION OF THE BURN DISEASE OUTCOME IN THE PATIENTS WITH SEVERE THERMAL TRAUMA | 2020 |
|
RU2738303C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING AUTOIMMUNE DISEASES ASSOCIATED WITH INCREASED NUCLEIC ACID ANTIBODY FORMATION | 2008 |
|
RU2401112C2 |
| AGENT FOR EVALUATION OF ENDOTOXEMIA MANIFESTATION AND DEGREE OF DISEASE SEVERITY | 1999 |
|
RU2176508C2 |
